Congratulations to 2 amazing colleagues Dr. Sadiya Khan & Chiadi Ndumele for leading this uber important AHA Scientific Statement on 🫀 risk prediction @CiccaroneCenter @HopkinsHeart

An absolute pleasure to record this podcast on the #AIEnabled Clinician w/ @AmiBhattMD, MD, CIO @ACCinTouch, on navigating #LLMs in Cardiology! We touch on the unique @ACCinTouch partnership with @EvidenceOpen. More to come! @SamyuktaMD @VivHo @hmkyale acc.org/Latest-in-Cardiology…

👇 Drs. @AmiBhattMD & @ankeetbhatt explore the impact of large language models (LLM) on CV care, share a practical framework for navigating LLMs, highlight important components to engineer an effective clinical prompt, & more. bit.ly/3PMYapk #ACCInnovation @EvidenceOpen

I’m pleased to share Mayo Clinic has announced a strategic collaboration with @Microsoft to develop and deploy a frontier AI model designed specifically for healthcare. Read more: newsnetwork.mayoclinic.org/d…

Congrats @TorBiering. So well deserved. Brilliant scientist, researcher, colleague and friend. Thanks for inspiring us! @CTCPR_

What do The Dave Brubeck Quartet and Advocate Health have in common? At Advocate Health, it used to take pharmacy staff up to 25 minutes to fill out a set of prior auth questions. Now, they only Take Five 🥁

Between rooms. On rounds. Walking the corridor outside an OR. Charting one-handed during a phone call. This is where clinical questions happen. Today we're launching Voice Mode. OpenEvidence is the first multimodal medical AI: physicians can type, speak, or listen, on the same evidence base. The clinician asks a clinical question out loud. Voice Mode waits when you pause, stops when you interrupt. The answer comes back concise, peer-reviewed, and verifiable against the source. Conversation with a colleague. That was the bar. For years we've focused on the intelligence: curation, retrieval, citations. Voice Mode is the interface catching up to where physicians practice. The evidence quality doesn't change with the modality. Voice answers are shorter and shaped for listening; the references and the full written form stay in the conversation. Voice Mode is now in OpenEvidence web and mobile.

Until now, physicians using AI in clinic had to assemble the patient’s context themselves. Allergies, comorbidities, medications, prior procedures, copy-pasted in from the chart. Today we’re announcing a partnership with @CedarsSinai. OpenEvidence now works directly inside Epic, drawing on the patient’s full record and interpreting the medical literature through the lens of that specific patient. Cedars-Sinai is the first academic health system to deploy patient-aware clinical intelligence at enterprise scale. The clinician asks a complex question in natural language. The answer reflects both the best available evidence and the patient in front of them. Patient data is never stored after the clinical session or used for any other purpose.

Ple as sure to host Dr Jyothis George today. Great friend and leader.

We need awesome doctors who can help develop AI doctors to make AI scalable for all primary care, chronic disease care, and parts of specialty care we call "multi-specialty primary care"! AI allows for this oxymoron. Make a difference globally

A fitting honor for an interventional legend. Congrats to Igor on an amazing career! #MGBInterventionalCardiology

Well deserved honor for my colleague/friend/mentor- a true great in the field who has been beacon for structural heart. #MGBInterventionalCardiology

We’re honored to announce that Dr. Patrick O’Gara is the recipient of the #TCT2026 Career Achievement Award! 🎉✨ Recognized for his extraordinary contributions to #cardiology and #interventionalcardiology, Dr. O’Gara has transformed patient care through clinical excellence, pioneering research, and exceptional mentorship. Celebrate his remarkable impact on the field in San Diego and learn more about this prestigious award! 👉 ow.ly/hP1n50YVbCE #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD @BrighamWomens @harvardmed

It was a pleasure to welcome Dr. Robert W. Yeh as our 16th Peter M. Yurchak Visiting Lecturer this last week at MGH. Thank you for your wisdom related to career building, future directions for device innovation, and much more!

What are the best strategies for overcoming these barriers?

🫀 Proud to share that @American_Heart has awarded $15M to study heart valve disease , including our @MassGenBrigham VALVE-iPROTECT Center Honored to work with Center Director @AikawaElena and co-investigators @SamiaMoraMD @toleafgirl , Daniel Chasman, Ahmed Tawakol & Olga Demler Our focus: early detection & prevention of aortic stenosis, with Lp(a) at the center. 🔗 newsroom.heart.org/news/scie… #ValveiPROTECT #HeartValve #AorticStenosis #Lpa #AHA #Cardiology @thecsanz @MGBResearchNews @MassGenBrigham @BrighamWomens @HarvardHealth @harvardmed

RT @coconnormd: It was a privilege to know Dr Braunwald for several decades . We collaborated on dozens of HF trials , from the planning an…

The cardiology community has lost a giant. We honor the extraordinary legacy of Eugene Braunwald, MD, MACC, a visionary leader and pioneer whose outstanding contributions shaped the foundation of cardiovascular medicine as we know it today. Read more: bit.ly/41NEXGp

The cardiology community mourns the loss of Dr. Eugene Braunwald, a towering figure whose work shaped modern cardiovascular medicine. From foundational discoveries in heart failure to Braunwald’s Heart Disease, his legacy will guide generations to come. A true giant in our field.

Check out the latest @hfsa scientific statement on HFmrEF. A must read for clinicians who take care of pts with HF. @dranulala @DrMarthaGulati @JCardFail